These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 10311207)

  • 1. Cost-effectiveness analysis as a tool to compare two methods of preparing and administering intravenous heparin solutions.
    Oszko MA; Fant WK
    Hosp Pharm; 1985 Aug; 20(8):576-8, 581-2. PubMed ID: 10311207
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cost containment associated with decreased parenteral antibiotic administration frequencies.
    Tanner DJ; Nazarian MQ
    Am J Med; 1984 Oct; 77(4C):104-11. PubMed ID: 6496524
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Twenty-four-hour single-container system for parenteral nutrient admixtures.
    Raebel MA; McDonald JB
    Am J Hosp Pharm; 1985 Jun; 42(6):1355-8. PubMed ID: 3925769
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Variable cost per dose of preparing and administering small-volume cephalosporin admixtures. Veterans Administration Pharmacy Service Study Group.
    Am J Hosp Pharm; 1984 Dec; 41(12):2624-34. PubMed ID: 6517086
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cost-effectiveness of standardized heparin and aminophylline solutions.
    Jenkins J; Brown T
    NITA; 1985; 8(2):162-4. PubMed ID: 3920579
    [No Abstract]   [Full Text] [Related]  

  • 6. Comparison of the cost-effectiveness of administering heparin subcutaneously or intravenously for the treatment of deep vein thrombosis.
    Barber ND; Hoffmeyer UK
    Ann R Coll Surg Engl; 1993 Nov; 75(6):430-3. PubMed ID: 8285546
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A cost comparison of intravenous cimetidine delivery systems.
    Jackson CW; Caldwell RD; Arford PD
    Hosp Pharm; 1990 Dec; 25(12):1085-9. PubMed ID: 10108250
    [TBL] [Abstract][Full Text] [Related]  

  • 8. IV additive program saves Montreal hospital $300,000.
    Torchinsky A
    Health Care (Don Mills); 1986 Jun; 28(5):25-8. PubMed ID: 10277322
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cost-benefit analysis of a hospital pharmacy bar code solution.
    Maviglia SM; Yoo JY; Franz C; Featherstone E; Churchill W; Bates DW; Gandhi TK; Poon EG
    Arch Intern Med; 2007 Apr; 167(8):788-94. PubMed ID: 17452541
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Personnel costs and preparation time in a centralized intravenous admixture program.
    Ryan DM; Daniels CE; Somani SM
    Am J Hosp Pharm; 1986 May; 43(5):1222-5. PubMed ID: 3087164
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cost-saving impact of pharmacist-calculated i.v. aminophylline dosing schedules.
    Cook CR; Bush ND
    Hosp Formul; 1989 Dec; 24(12):716-7, 721. PubMed ID: 10296551
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Minimizing i.v. admixture waste in a 70-bed hospital.
    Tullio CJ
    Hosp Pharm; 1987 Oct; 22(10):994, 997, 1001. PubMed ID: 10284567
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A cost benefit comparison of two antibiotic delivery systems in a children's hospital.
    O'Brodovich ML
    Can J Hosp Pharm; 1985 Oct; 38(5):144-6. PubMed ID: 10311321
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Strategies for reducing i.v. drug waste and coping with increased workload.
    Hoolihan RJ; Erickson BA
    Hosp Pharm; 1987 Sep; 22(9):871-6. PubMed ID: 10312222
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Cost-benefit analysis of a semi-automated process in the preparation of unit-doses by the Pharmacy Department].
    Poveda Andrés JL; Hernández Sansalvador M; Díez Martínez AM; García Gómez C
    Farm Hosp; 2004; 28(2):76-83. PubMed ID: 15101798
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Economic impact of an automated dispensing system in an intensive care unit].
    Kheniene F; Bedouch P; Durand M; Marie F; Brudieu E; Tourlonnias MM; Bongi P; Allenet B; Calop J
    Ann Fr Anesth Reanim; 2008 Mar; 27(3):208-15. PubMed ID: 18272320
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intravenous nitroglycerin delivery: dynamics and cost considerations.
    Nix DE; Tharpe WN; Francisco GE
    Hosp Pharm; 1985 Apr; 20(4):230-2. PubMed ID: 10311085
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Design of a safer approach to intravenous drug infusions: failure mode effects analysis.
    Apkon M; Leonard J; Probst L; DeLizio L; Vitale R
    Qual Saf Health Care; 2004 Aug; 13(4):265-71. PubMed ID: 15289629
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Buprenorphine: a cost-effective alternative to Schedule II analgesics for moderate to severe pain relief.
    Rosenthal MH; Bayait F
    Hosp Formul; 1988 Jan; 23(1):57-60, 62, 71. PubMed ID: 10312332
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cost savings and effectiveness of outpatient treatment with low molecular weight heparin of deep vein thrombosis in a community hospital.
    Lee M; Pao D; Hsu T; Sonderskov A
    Can J Clin Pharmacol; 2004; 11(1):e17-27. PubMed ID: 15226523
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.